Kraig Biocraft Laboratories

OverviewSuggest Edit

Kraig Biocraft Laboratories is a biotechnology company focused on the development and commercialization of genetically engineered spider silks. It applies its proprietary genetic engineering technology to find solutions in the areas of material science.
TypePublic
Founded2006
HQAnn Arbor, MI, US
Websitekraiglabs.com

Latest Updates

Employees (est.) (Dec 2019)14
Revenue (FY, 2018)$401.6 K(+313%)
Share Price (Oct 2021)$0.1
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Kraig Biocraft Laboratories

Kim Thompson

Kim Thompson

Chairman
Kim K. Thompson

Kim K. Thompson

Founder and CEO
Jon Rice

Jon Rice

COO
Show more

Kraig Biocraft Laboratories Office Locations

Kraig Biocraft Laboratories has an office in Ann Arbor
Ann Arbor, MI, US (HQ)
2723 S State St #150
Show all (1)

Kraig Biocraft Laboratories Financials and Metrics

Kraig Biocraft Laboratories Revenue

Kraig Biocraft Laboratories's revenue was reported to be $401.62 k in FY, 2018
USD

Net income (FY, 2020)

(5.0m)

EBIT (FY, 2020)

(4.5m)

Market capitalization (15-Oct-2021)

68.2m

Closing stock price (15-Oct-2021)

0.1

Cash (31-Dec-2020)

816.9k

EV

69.7m
Kraig Biocraft Laboratories's current market capitalization is $68.2 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

31.9k97.3k401.6k

Sales and marketing expense

General and administrative expense

786.9k379.3k1.4m896.1k920.9k1.7m1.2m515.9k1.4m3.5m

R&D expense

250.6k465.3k489.4k439.5k432.0k397.1k258.9k148.1k223.1k88.5k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

18.7k27.2k108.6k152.2k140.8k

Sales and marketing expense

General and administrative expense

141.5k251.6k60.8k230.2k67.2k27.5k33.3k772.5k452.9k342.5k31.3k156.5k643.1k55.0k117.9k106.8k821.7k151.6k904.9k65.3k181.7k99.3k123.7k118.0k122.2k826.6k2.8m348.3k

R&D expense

140.9k210.0k145.4k155.3k164.8k96.4k116.1k108.1k68.8k79.6k143.5k90.7k110.7k139.9k129.3k114.2k51.4k25.4k20.1k50.9k20.2k22.3k20.9k44.0k4.8k33.0k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

195.4k53.8k295.4k495.0k238.2k298.9k18.2k13.7k125.0k816.9k

Accounts Receivable

31.9k25.9k

Prepaid Expenses

2.3k1.7k1.0k645.01.3k4.5k6.9k31.7k2.6k

Current Assets

201.4k62.2k297.1k496.0k238.8k332.0k48.5k20.6k156.8k819.5k
USDQ2, 2011

Financial Leverage

-0.2 x
Show all financial metrics

Kraig Biocraft Laboratories Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Kraig Biocraft Laboratories Online and Social Media Presence

Embed Graph

Kraig Biocraft Laboratories News and Updates

Kraig Biocraft Laboratories Announces Breakthrough in Creation of New Recombinant Spider Silks

Kraig Labs files provisional patent for next-generation gene-editing system Kraig Labs files provisional patent for next-generation gene-editing system

Kraig Biocraft Laboratories Prepares for Challenge Testing of Disease Resistant Silkworm Lines

Immunity enhanced silkworms provide licensing opportunities into the broader $14 B1 silk industry

Kraig Biocraft Laboratories Creates Second Generation of Recombinant Spider Silk Silkworms at New Production Headquarters

Follows Prodigy’s successful First Batch at New Facility in August Follows Prodigy’s successful First Batch at New Facility in August

Kraig Biocraft Laboratories Adds European Union to Ever-growing Portfolio of Spider Silk Patents

ANN ARBOR, Mich., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that it has been granted patent protection for its recombinant spider silk technologies in the Eur…

Kraig Biocraft Laboratories Completes Transition of Production Operations to Custom Designed Silk Rearing Facility

Kraig Labs takes possession of silkworm rearing and breeding facility in the heart of Vietnamese agriculture district Kraig Labs takes possession of silkworm rearing and breeding facility in the heart of Vietnamese agriculture district

Kraig Biocraft Laboratories Welcomes New Senior Scientist

ANN ARBOR, Mich., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today the expansion of its development team with the addition of a new senior scientist. Dr. Jimi Miller…
Show more

Kraig Biocraft Laboratories Blogs

Kraig Biocraft Laboratories Delivers First Sample Fabrics to Spydasilk Enterprises

ANN ARBOR, Mich., – September 23, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it has delivered the first fabric samples to Spydasilk Enterprises (“Sp…

Kraig Biocraft Laboratories Completes Installation of Automated Production Equipment

Kraig Labs bring new automated processing equipment to expedite silk processing   ANN ARBOR, Mich., – June 23, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today…

Kraig Biocraft Laboratories Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subsidiary

Equipment transfer positions Prodigy to expedite production expansion and next-generation disease-resistant silkworms ANN ARBOR, Mich., – June 7, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercializat…

Kraig Biocraft Laboratories Secures $4 Million Dollars of Expansion Capital

ANN ARBOR, Mich., – March 26, 2021 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced today that it has secured $4 million dollars of expansion capital.  This financing significantly strengthens the Company’s balance sheet and supports its progress in the commerc…

Kraig Biocraft Laboratories Secures Bridge Funding and Files to Become Fully Reporting Company

ANN ARBOR, Mich., – December 11, 2020 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced today that it has secured $950,000 in bridge financing and simultaneously filed with the SEC to become a mandatory, fully reporting company.  “While being a voluntary filer, …

Kraig Biocraft Laboratories Frequently Asked Questions

  • When was Kraig Biocraft Laboratories founded?

    Kraig Biocraft Laboratories was founded in 2006.

  • Who are Kraig Biocraft Laboratories key executives?

    Kraig Biocraft Laboratories's key executives are Kim Thompson, Kim K. Thompson and Jon Rice.

  • How many employees does Kraig Biocraft Laboratories have?

    Kraig Biocraft Laboratories has 14 employees.

  • Who are Kraig Biocraft Laboratories competitors?

    Competitors of Kraig Biocraft Laboratories include Explora Biotech, Novellus and Pencil Biosciences.

  • Where is Kraig Biocraft Laboratories headquarters?

    Kraig Biocraft Laboratories headquarters is located at 2723 S State St #150, Ann Arbor.

  • Where are Kraig Biocraft Laboratories offices?

    Kraig Biocraft Laboratories has an office in Ann Arbor.

  • How many offices does Kraig Biocraft Laboratories have?

    Kraig Biocraft Laboratories has 1 office.